Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Deflazacort
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Deflazacort 6mg tablets
0603020I0AAAAAA
|
Deflazacort | Deflazacort | Endocrine System | 1,643 |
|
Calcort 6mg tablets
0603020I0BBAAAA
|
Calcort | Deflazacort | Endocrine System | 59 |
|
Calcort 1mg tablets
0603020I0BBACAD
|
Calcort | Deflazacort | Endocrine System | No data available |
|
Calcort 30mg tablets
0603020I0BBABAC
|
Calcort | Deflazacort | Endocrine System | No data available |
|
Deflazacort 1mg tablets
0603020I0AAADAD
|
Deflazacort | Deflazacort | Endocrine System | No data available |
|
Deflazacort 22.75mg/1ml oral suspension
0603020I0AAAFAF
|
Deflazacort | Deflazacort | Endocrine System | No data available |
|
Deflazacort 30mg tablets
0603020I0AAACAC
|
Deflazacort | Deflazacort | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.